We are live on ! Find out more
WE

Wealth Effects Portfolio holdings

AUM $282M
1-Year Est. Return 62.81%
This Fund
S&P 500
This Quarter Est. Return
-19.17%
1 Year Est. Return
+62.81%
3 Year Est. Return
+160.11%
5 Year Est. Return
10 Year Est. Return
AUM
$166M
AUM Growth
-$48.1M
Cap. Flow
+$1.67M
Cap. Flow %
1.01%
Top 10 Hldgs %
35.36%
Holding
217
New
13
Increased
89
Reduced
57
Closed
28

Sector Composition

1 Technology 24.35%
2 Healthcare 23.71%
3 Financials 9.68%
4 Communication Services 8.4%
5 Consumer Discretionary 6.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFX
176
DELISTED
BowFlex Inc.
BFX
$122K 0.07%
69,764
+19,256
+38% +$53.2K
GGT
177
Gabelli Multimedia Trust
GGT
$173M
$121K 0.07%
16,951
-2,540
-13% -$19.5K
NVTA
178
DELISTED
Invitae Corporation
NVTA
$117K 0.07%
48,130
+4,025
+9% +$17.8K
AUTL
179
Autolus Therapeutics
AUTL
$383M
$108K 0.07%
38,100
+6,450
+20% +$19.6K
ET icon
180
Energy Transfer Partners
ET
$69.9B
$100K 0.06%
10,000
-672
-6% -$7.53K
IBRX icon
181
ImmunityBio
IBRX
$8.04B
$60K 0.04%
16,000
+5,000
+45% +$20.1K
STXS icon
182
Stereotaxis
STXS
$154M
$58K 0.03%
31,560
+800
+3% +$1.91K
HYFM icon
183
Hydrofarm Holdings
HYFM
$3.25M
$56K 0.03%
1,618
+485
+43% +$39.5K
IMDX
184
Insight Molecular Diagnostics
IMDX
$153M
$44K 0.03%
2,450
CURI icon
185
CuriosityStream
CURI
$152M
$27K 0.02%
15,901
+50
+0.3% +$101
AMRN
186
Amarin Corp
AMRN
$292M
$26K 0.02%
875
ATHX
187
DELISTED
Athersys, Inc. Common Stock
ATHX
$21K 0.01%
3,284
AKBA icon
188
Akebia Therapeutics
AKBA
$359M
$6K ﹤0.01%
18,316
-512
-3% -$215
CATX icon
189
Perspective Therapeutics
CATX
$341M
$3K ﹤0.01%
1,000
ACN icon
190
Accenture
ACN
$87.9B
-649
Closed -$219K
ADBE icon
191
Adobe
ADBE
$94.3B
-1,112
Closed -$507K
C icon
192
Citigroup
C
$217B
-8,375
Closed -$447K
CMI icon
193
Cummins
CMI
$89.5B
-1,010
Closed -$207K
CRM icon
194
Salesforce
CRM
$140B
-1,170
Closed -$248K
CSCO icon
195
Cisco
CSCO
$441B
-3,761
Closed -$210K
CSM icon
196
ProShares Large Cap Core Plus
CSM
$512M
-4,203
Closed -$226K
DKNG icon
197
DraftKings
DKNG
$12.4B
-12,836
Closed -$250K
DTE icon
198
DTE Energy
DTE
$30.8B
-1,591
Closed -$210K
FCX icon
199
Freeport-McMoran
FCX
$83.9B
-4,825
Closed -$240K
FPX icon
200
First Trust US Equity Opportunities ETF
FPX
$1.5B
-1,967
Closed -$215K

Similar funds

Wealth Effects's Q2 2022 Portfolio in Review

As of Q2 2022, Wealth Effects held 217 positions worth $166M, down 22% from $214M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Wealth Effects's Q2 2022 filing shows 13 new, 89 increased, 57 reduced and 28 closed positions. Its largest new stake was indie Semiconductor: 204,951 shares worth $1.17M. The largest sale was Teladoc Health, an estimated $1.22M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Wealth Effects's largest Q2 2022 buy was indie Semiconductor: 204,951 shares worth $1.17M.
  • Wealth Effects added most to Apple in Q2 2022, an estimated $964K increase.
  • Wealth Effects's biggest Q2 2022 reduction was Walt Disney, cutting an estimated $298K.
  • Wealth Effects fully exited Teladoc Health in Q2 2022, selling an estimated $1.22M.
  • Wealth Effects's ten largest holdings make up 35% of its $166M portfolio in Q2 2022.
  • Wealth Effects opened 13 new positions and closed 28 in Q2 2022.
  • Wealth Effects's portfolio value fell 22% quarter-over-quarter to $166M.

Based on Wealth Effects's 13F filing for Q2 2022, filed 3 Aug 2022.